Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions.
about
Human host factors required for influenza virus replicationIdentification of potential conserved RNA secondary structure throughout influenza A coding regionsExperimental Approaches to Study Genome Packaging of Influenza A VirusesThe Feat of Packaging Eight Unique Genome SegmentsProtective immunity and safety of a genetically modified influenza virus vaccineReverse Genetics Approaches for the Development of Influenza VaccinesInfluenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cellsHigh-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolutionInfluenza A and B virus intertypic reassortment through compatible viral packaging signals.New insights into the nonconserved noncoding region of the subtype-determinant hemagglutinin and neuraminidase segments of influenza A viruses.A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin ProteinCompetitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).Oligonucleotides derived from the packaging signal at the 5' end of the viral PB2 segment specifically inhibit influenza virus in vitro.Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene.Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.Three-dimensional analysis of ribonucleoprotein complexes in influenza A virusImprovement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infectionPseudotyped influenza A virus as a vaccine for the induction of heterotypic immunityInfluenza virus exploits tunneling nanotubes for cell-to-cell spread.Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences.Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.Broad protection against influenza infection by vectored immunoprophylaxis in mice.Reassortment process after co-infection of pigs with avian H1N1 and swine H3N2 influenza viruses.The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin.A nine-segment influenza a virus carrying subtype H1 and H3 hemagglutinins.Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulationGeneration of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segmentAn in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus.Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration.Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis.A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEFInfluenza virus reassortment occurs with high frequency in the absence of segment mismatch.The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expressionNrf2 expression modifies influenza A entry and replication in nasal epithelial cells.Taming influenza viruses.A supramolecular assembly formed by influenza A virus genomic RNA segmentsDownregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells
P2860
Q24629972-2140C380-CC35-4C1F-B9CE-BA74676B3774Q24633659-EB16451D-060F-49F4-AFDD-BF6ACB9481CAQ26741606-BA7CFE62-F6B9-4DE7-82A5-6144F4EBE32DQ26744324-958BC23B-8F95-4D16-AA21-C5331AD4B29BQ27324763-863494A1-7B38-43CD-B3F4-0B2CA2BE11B6Q28076140-747EC760-E390-4EC1-8454-98EBF9667FB2Q28650894-BDDB0E71-03D7-4BAD-A14B-D7EA146606CFQ30362478-252565DE-9F50-4FA0-9192-E74856C6A3F5Q30364518-8A704119-526E-4E9C-8C0F-E358F35A390FQ30365054-5706C85C-CCBF-462D-8A9E-6913980085A9Q30374768-74ECB20C-82AC-4461-8162-694657DA8384Q30375314-D349DD2D-61D3-4A3D-A7EC-F844C3D1BCB5Q30376184-20F59AF4-CE5C-4C48-B444-40F796589B68Q30392174-7F9008A5-F1C4-4601-9B88-719F85620A72Q30401820-6FA2D44A-FA5C-4F30-97EA-A956AEC31A55Q30412156-E56F8B8C-7D92-495E-819F-3EB1E1A44652Q30414388-4F7F0821-BE29-4DDF-8158-488361116A43Q30415297-8B2D7151-9712-441A-BDCD-36032F0E37ABQ30421682-58051BE4-8F4C-4F72-92E9-75E5C7E89559Q30833966-EB507806-BFB2-4F96-A904-3415BDABC99DQ33419611-5EA46D97-66A2-4098-AE2C-ABD1E3A5A0E6Q33614564-96818A81-D17F-4698-B93D-058DB428A4E8Q33649040-8AB6C9F5-85E1-4AC2-88E6-699D5D3A6B5AQ33885285-1CA48504-87C0-42CE-8ADA-3AD1852AC261Q33943327-4FCAF217-630E-4615-AD8A-C6E424ABA109Q34046208-6F8B0975-8A63-440A-89D8-0FCB5478BA1EQ34261441-9C29456A-994B-43BB-A3F3-F419618CD91EQ34277968-1FF9077E-A8C7-4DC6-8034-26405BE6872AQ34296134-7F586976-723E-4BE8-B62A-F7734CBC2C07Q34503923-C055D192-F37C-4E89-9C28-D11E1D6BED08Q34594479-5347E095-69A2-48B2-BF2D-92A597ED99EFQ34720292-03B4C5F7-92CE-4232-BA90-1D35067E8D40Q34775136-5C3BF83D-FE87-4565-A7AF-E0F519F6CFEAQ34778503-AB4C35C3-5D72-4DF8-ABEB-7FCE132508A2Q35069349-F150C5C6-F4ED-4EFC-A424-E733FFAA35FAQ35103126-C1E967CA-3977-4AD7-8A33-6D22628B120BQ35571169-D74AE2A0-28D5-4E40-B1AB-5DEE88FF84ECQ35823770-794F693F-B987-48BA-8521-53191E25CC32Q35869278-C2EC913A-D711-4608-ADC8-32B68DD68C3AQ35991598-A7D43177-7731-4A89-BF8D-9D5F9682DFC3
P2860
Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Specific residues of the influ ...... ackaging into budding virions.
@en
type
label
Specific residues of the influ ...... ackaging into budding virions.
@en
prefLabel
Specific residues of the influ ...... ackaging into budding virions.
@en
P2860
P356
P1433
P1476
Specific residues of the influ ...... ackaging into budding virions.
@en
P2093
Glenn A Marsh
Raheleh Hatami
P2860
P304
P356
10.1128/JVI.01144-07
P407
P50
P577
2007-07-18T00:00:00Z